Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study

INTRODUCTION: Intravenous vernakalant is a therapeutic option for symptomatic, recent-onset atrial fibrillation (AF). This secondary analysis from the large SPECTRUM study assessed the safety and effectiveness of vernakalant when used in the emergency department setting (ED group) or in an inpatient...

Descripción completa

Detalles Bibliográficos
Autores principales: Bager, Johan-Emil, Martín, Alfonso, Carbajosa Dalmau, José, Simon, Alexander, Merino, José L., Ritz, Beate, Hartikainen, Juha E.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
AF and Stroke: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808723/
https://www.ncbi.nlm.nih.gov/pubmed/36282074
http://dx.doi.org/10.1159/000526831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808723/
https://www.ncbi.nlm.nih.gov/pubmed/36282074
http://dx.doi.org/10.1159/000526831

Ejemplares similares